Safety, Tolerability and Pharmacokinetics of EM-I-2024

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

Enrollment

OTHER

Sponsor class

Conditions

Assess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor

BIOLOGICAL: Two cohorts of patients: intravenous administration and intra-arterial administration with dose escalation of the drug.

National Medical Research Radiological Centre of the Ministry of Health of Russia